Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)

    This grant supports creating and validating animal models and tissue systems mimicking neurological disorders to advance neurotherapeutic discovery.

    Browse similar grants
    Neuroscience Research Grants 2026Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

    Grant supports developing assays to find new therapies for brain and muscle diseases within IGNITE program; doesn't fund clinical trials.

    HHS-NIH11Due Feb 18, 2027$750,000

    Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)

    Funding support available to study and prove effectiveness of potential neurotherapeutic agents for neurological disorders towards further development.

    HHS-NIH11Due Feb 18, 2027

    Translational Neural Devices (R61/R33 - Clinical Trial Optional)

    Encourages translational activities and small clinical studies for neural devices to address disorders affecting the nervous system; includes prototype development, safety testing, and clinical validation.

    HHS-NIH11Due Jan 28, 2027

    Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)

    Funding for developing biomarkers to aid in clinical development of neurotherapeutics for neurological and neuromuscular disorders.

    HHS-NIH11Due Feb 22, 2027

    NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)

    NIH supports development of next-generation diagnostic and therapeutic devices aligned with its brain research and addiction initiatives, preparing them for first-in-human trials; clinical trials are not allowed.

    HHS-NIH11Due Feb 1, 2027$2,250,000